首页> 外文期刊>British journal of ophthalmology >Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy
【24h】

Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy

机译:质子束放射治疗后经巩膜局部切除毒性脉络膜黑色素瘤

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim: To report on trans-scleral local resection of choroidal melanoma for exudative retinal detachment and neovascular glaucoma (toxic tumour syndrome) after proton beam radiotherapy (PBR). Methods: A non-randomised, prospective study of secondary trans-scleral local resection of choroidal melanoma for exudative retinal detachment with or without neovascular glaucoma after PBR. The patients were treated at the Liverpool Ocular Oncology Centre between February 2000 and April 2008. The transscleral local resection was performed with a lamellarscleral flap, using systemic hypotension to reduce haemorrhage. Results: 12 patients (six women, six men) with a mean age of 51 years (range 20-75) were included in this study. The tumour margins extended anterior to ora serrata in six patients. On ultrasonography, the largest basal tumour dimension averaged 12.4 mm (range 6.8-18.1) and the tumour height averaged 7.1 mm (range 4.2-10.7). The retinal detachment was total in seven patients. Neovascular glaucoma was present in four patients. The time between PBR and local resection had a mean of 17.4 months (range 1-84). The ophthalmic follow-up time after the local resection had a mean of 46.2 months (range 14-99). At the latest known status, the eye was conserved in 10 patients, with a flat retina in all these patients and visual acuity equal or better than 6/30 in four patients. The reasons for enucleation were: patient request for enucleation when rhegmatogenous retinal detachment complicated the resection (one patient) and phthisis (one patient). Conclusions: Exudative retinal detachment, rubeosis and neovascular glaucoma after PBR of a choroidal melanoma can resolve after trans-scleral local resection of the tumour. Our findings suggest that these complications are caused by the persistence of the irradiated tumour within the eye ('toxic tumour syndrome').
机译:目的:报道经质子束放射治疗(PBR)后脉络膜黑色素瘤的巩膜局部切除术,用于渗出性视网膜脱离和新生血管性青光眼(毒性肿瘤综合征)。方法:一项非随机,前瞻性研究,对PBR后继发性巩膜性黑色素瘤经巩膜局部切除术治疗渗出性视网膜脱离伴或不伴新生血管性青光眼。在2000年2月至2008年4月之间,这些患者在利物浦眼肿瘤中心接受了治疗。经巩膜片皮瓣进行巩膜局部切除术,并使用全身性低血压减少出血。结果:12例患者(六名女性,六名男性)平均年龄为51岁(范围为20-75)。 6例患者的肿瘤边缘向锯齿缘延伸。在超声检查中,最大的基底肿瘤尺寸平均为12.4 mm(范围6.8-18.1),肿瘤高度平均为7.1 mm(范围4.2-10.7)。共有7例视网膜脱离。四名患者出现新血管性青光眼。 PBR和局部切除之间的时间平均为17.4个月(范围1-84)。局部切除后的眼科随访时间平均为46.2个月(范围14-99)。在最新的已知状态下,有10位患者的眼睛是保守的,所有这些患者的视网膜都是平坦的,并且有4位患者的视力等于或优于6/30。摘除的原因是:当流源性视网膜脱离使切除术(一名患者)和睑裂(一名患者)复杂化时,患者要求摘除。结论:脉络膜黑色素瘤经巩膜局部切除后,渗出性视网膜脱离,红肿和新生血管性青光眼可解决。我们的研究结果表明,这些并发症是由眼睛内照射的肿瘤持续存在引起的(“毒性肿瘤综合症”)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号